242 related articles for article (PubMed ID: 31848941)
1. Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer.
Yu C; Chen J; Ma J; Zang L; Dong F; Sun J; Zheng M
Pathol Oncol Res; 2020 Jul; 26(3):1903-1919. PubMed ID: 31848941
[TBL] [Abstract][Full Text] [Related]
2. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods.
Liu J; Cheng Z
Comb Chem High Throughput Screen; 2023; 26(4):653-667. PubMed ID: 35996248
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
Qiu J; Sun M; Wang Y; Chen B
Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes correlated with the pathogenesis and prognosis of gastric cancer via bioinformatics methods.
Nie K; Shi L; Wen Y; Pan J; Li P; Zheng Z; Liu F
Minerva Med; 2020 Jun; 111(3):213-225. PubMed ID: 31638362
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer.
Wang Y; Zheng K; Chen X; Chen R; Zou Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345281
[TBL] [Abstract][Full Text] [Related]
7. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
9. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
[No Abstract] [Full Text] [Related]
10. High expression of ghrelin and obestatin prepropeptide in tumor tissues predicted adverse overall survival in gastric carcinoma patients.
Wu X; Wu Y; Ye B; Wu F; Wang P
Medicine (Baltimore); 2020 Jun; 99(26):e20635. PubMed ID: 32590738
[TBL] [Abstract][Full Text] [Related]
11. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
12. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis for exploring hub genes and related mechanisms affecting the progression of gastric cancer.
Wang Y; Li D; Li D; Wang H; Wu Y
Biotechnol Genet Eng Rev; 2023 May; ():1-12. PubMed ID: 37243583
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
[TBL] [Abstract][Full Text] [Related]
15. Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis.
Chong X; Peng R; Sun Y; Zhang L; Zhang Z
Biomed Res Int; 2020; 2020():7658230. PubMed ID: 33015179
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
17. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
[No Abstract] [Full Text] [Related]
18. Bioinformatic analysis of potential hub genes in gastric adenocarcinoma.
Liu H; Qu Y; Zhou H; Zheng Z; Zhao J; Zhang J
Sci Prog; 2021; 104(1):368504211004260. PubMed ID: 33788653
[TBL] [Abstract][Full Text] [Related]
19. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M
World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903
[TBL] [Abstract][Full Text] [Related]
20. Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG.
Duan S; Gong B; Wang P; Huang H; Luo L; Liu F
Mol Med Rep; 2018 Oct; 18(4):3727-3736. PubMed ID: 30106150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
